AUG 08, 2018 5:50 AM PDT

Injection Improves Corneal Transplant Outcomes

WRITTEN BY: Nouran Amin

The common form of tissue transplant is the corneal transplant. Corneal transplantation is performed to correct visual loss that has occurred when the cornea, the transparent structure forming the front of the eye, becomes opaque (cloudy) as a result of many eye diseases.

According to a research study in the American Journal of Pathology, Injection of neuropeptide vasoactive intestinal peptide (VIP) directly into the eye of mouse models was found to enhance corneal graft survival. The injection was also found to produce other benefits such as accelerating wound healing, protecting corneal endothelial cells, and improving the corneal graft clarity. If VIP is shown successfully in clinical studies, the novel approach may bring hope to patients who lost their vision due to corneal disease. "The successful outcome of corneal transplantation mainly relies on the density and function of CEnCs, which keep the graft transparent. To improve the outcomes of corneal transplantation, various strategies have been employed to prevent immune-mediated graft rejection or enhance survival and function of CEnCs. However, an effective method has remained elusive so far," explains Dr. Ahmad Kheirkhah of the University of Texas San Antonio. During the study, researchers evaluated the effect of VIP on corneal tissue in cell culture and living animals who received corneal transplants.

VIP is a 28-amino acid neuropeptide found in the aqueous humor of the eye and may be secreted by corneal endothelial cells. It is recognized as a protection and immunoregulation factor in multiple organ systems. In mice that underwent corneal transplantation, grafts were more transparent in VIP-treated mice comparison to the controls. After eight weeks since transplantation, 85 percent of VIP-treated grafts have survived in comparison to only 0 percent of control grafts. Additionally, corneal endothelial cell density was higher in VIP-treated corneas than controls. "Millions of patients around the world are blind due to corneal opacity, and they are in dire need of corneal transplantation. Unfortunately, there is a significant shortage of donor corneas across the world. On the other hand, many donated corneas cannot be used for transplantation due to inadequate endothelial cells. Moreover, corneal transplants can deteriorate over time due to continuous loss of CEnCs," noted Reza Dana, MD, MPH, MSc, Professor of Ophthalmology at the Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. "If confirmed in further clinical studies, we believe that the use of VIP will increase the number of donated corneas suitable for transplantation and improve the outcomes of corneal transplantation."

 

Source: Elsevier

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 24, 2020
Cancer
A New Biomarker Candidate for Cancer Diagnostics
JUL 24, 2020
A New Biomarker Candidate for Cancer Diagnostics
One of the best tools in the fight against cancer is diagnostics. In 2018, colorectal cancer was the second most lethal ...
JUL 20, 2020
Technology
Robots as Models for Medicated Chewing Gum
JUL 20, 2020
Robots as Models for Medicated Chewing Gum
A robot with the ability to chew can provide useful insights on medicated chewing gum for pharmaceutical companies. The ...
AUG 19, 2020
Cancer
Testing the Toxicity of CDK Inhibitors and Radiotherapy
AUG 19, 2020
Testing the Toxicity of CDK Inhibitors and Radiotherapy
Drug targets often focus on one thing, inhibiting or activating some critical function in a cell. Cancer drugs are no di ...
AUG 16, 2020
Cannabis Sciences
Cannabinoids May Interact with Prescribed Medications
AUG 16, 2020
Cannabinoids May Interact with Prescribed Medications
Despite the growing popularity of cannabis products, information is currently limited on how they may interact with othe ...
AUG 01, 2020
Drug Discovery & Development
Harnessing The Power of Synthetic Lethality
AUG 01, 2020
Harnessing The Power of Synthetic Lethality
Studies into genome sequencing has pushed researchers to harness the power of "synthetic lethality" in exploit ...
AUG 25, 2020
Drug Discovery & Development
The Potential of Antivitamins
AUG 25, 2020
The Potential of Antivitamins
What exactly are antivitamins? They are substances no less that have the power to target the biological function of a ge ...
Loading Comments...